查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生物材料伤口敷料市场-2022-2029
市场调查报告书
商品编码
1140682

全球生物材料伤口敷料市场-2022-2029

Global Biomaterial Wound Dressing Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

在预测期内，不断上升的伤口感染推动市场增长

由于卫生条件差、糖尿病、肥胖等导致伤口感染的发病率不断增加，这促进了伤口敷料市场的增长。伤口敷料用于通过将其应用于感染区域来减少伤口感染。感染是不方便的、痛苦的，并导致伤口癒合失败或延迟。在某些情况下，伤口感染非常严重，会导致坏死性蜂窝织炎和筋膜炎，扩散到局部骨骼、肌腱和关节组织，并导致全身性疾病和转移到脊柱等远处部位。

此外，由于全球手术数量的增加，全球生物材料伤口敷料市场正在经历显着增长。此外，随着整形手术的增加，它被应用于整形手术的伤口癒合，带动了伤口敷料市场。在美国，外科和非外科整容手术正在兴起。例如，到 2021 年，美国将进行超过 550 万例涉及毒素和填充物的手术，将有 491,000 人接受这些手术。

地理渗透。

北美是预测期内的主要地区。

在预测期内，北美市场占全球生物材料伤口敷料市场的最大市场份额。促进北美市场增长的因素包括压力性溃疡发病率的增加和烧伤人数的增加。此外，估计外科手术数量的增加和主要参与者的存在也有助于市场的增长。

此外，亚太地区正在经历全球最高的人口老龄化率，加上整个亚太经济体的溃疡患病率、烧伤事件增加和糖尿病患病率上升。预计该地区将以復合年增长率增长.到2020年，预计老年人口将达到2.55亿，至少占中国总人口的17.8%。随着年龄的增长，预计亚太地区人口中的溃疡病例会增加，这被认为会增加伤口的可能性。

竞争格局。

生物材料伤口敷料市场由少数公司主导。市场增长参与者包括 3M 公司、ConvaTec Group PLC、DermaRite Industries LLC、B. Braun Melsungen AG、Hollister Incorporated、Integra LifeSciences Holdings Corporation、强生公司和美敦力公司。预计主要参与者将执行多项增长战略，例如产品发布、收购和合作，这将推动全球生物材料伤口敷料市场。 2022 年 8 月，3M Health Care 的医疗解决方案业务宣布升级以加速某些伤口护理技术的交付。这种名为 3M VAC Ulta 治疗装置的新型生物材料伤口装置是免费向客户推出的。用于开放性软组织伤口的患者，以帮助促进清洁和肉芽组织的形成。当需要立即清洁伤口时，该套件有助于软化、溶解、破坏和去除厚的或不易腐烂的组织。 3M 公司提供范围广泛的伤口护理解决方案。 3M 开发了一种新的敷料套件，以简化各种敷料的应用。 2022 年 1 月，ConvaTec 集团签订了收购 Triad LifeSciences, Inc. 的最终协议，该公司是一家创新生物衍生产品的开发商，用于满足外科伤口、慢性伤口和烧伤方面未满足的临床需求。此次收购加强了 Convatec 在美国的先进伤口护理地位，提供了一个创新的技术平台，可改善先进的伤口管理和患者治疗效果。

COVID-19 的影响将对全球生物材料伤口敷料市场产生负面影响。

预计 COVID-19 大流行的爆发将破坏 2020 年生物材料伤口敷料市场的增长。事故和医院就诊次数的下降是对 2020 年生物材料伤口敷料市场增长产生负面影响的主要因素。但是，预计市场将受到更严格的锁定要求的负面影响，以避免 COVID-19 污染和由于远程办公设施而减少的交通事故。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品划分的市场细分
  • 按应用划分的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 增加外科手术
      • 运动伤害增加
    • 限制
      • 对高级伤口护理产品的认知度低
    • 商机
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品分类

  • 水胶体
  • 海藻酸盐敷料
  • 皮肤替代品
  • 其他

第 8 章按应用程序

  • 伤口
  • 烧伤
  • 溃疡
  • 其他

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第 11 章公司简介

  • 3M 公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • B. Braun Melsungen AG
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Molnlycke Health Care AB
  • Smith & Nephew PLC
  • Hunan Sanzhong Medical Dressing Co., Ltd.
  • Changzhou Hualian Health Dressing Co., Ltd.
  • Yangzhou Super Union Medical Material Co., Ltd.
  • Other Companies（*LIST NOT EXHAUSTIVE）

第12章 DataM

简介目录
Product Code: DMHCIT2975

Market Overview

Biomaterial Wound Dressing Market is expected to grow at a CAGR of 10.8% during the forecasting period (2022-2029).

Biomaterial wound healing can be categorized in several ways, depending on its chemical nature, source, type of dressing, or application. Synthetic biomaterials consist of organic and inorganic polymers. In contrast, natural biomaterials include biological products derived from plant, fungal, animal, or bacterial sources that can, in turn, be divided into proteins, polysaccharides, or macromolecules combining proteins and polysaccharides. The rising incidence of chronic wounds such as ulcers is significantly creating the demand for wound dressing products, augmenting the market growth. The rising incidence of wound infection and an increasing number of surgeries also demand advanced and traditional wound care products.

Market Dynamics: Rising incidence of wound infection drives the market's growth during the forecast period.

The increasing incidence of wound infection due to poor hygiene, diabetes, obesity, and others contributes to the growth of the wound dressing market. The wound dressing is used to reduce the wound infection by placing it on the infection area. Infections are inconvenient and painful and lead to failure or delay in wound healing. In some cases, wound infection is very severe, causing necrotizing cellulitis or fasciitis; it spreads into the local bone, tendon, or joint tissues; systemic disease or metastatic spread to the spine or other distant sites.

Moreover, the global biomaterial wound dressing market is experiencing significant growth due to the increasing number of surgeries worldwide. Moreover, the increasing number of plastic surgeries is driving the wound dressing market due to its application for wound healing in plastic surgeries. The increasing number of surgical and nonsurgical cosmetic procedures in the United States is significant. For instance, in 2021, more than 5.5 million procedures involved toxins and fillers, and 491 thousand performed surgeries in the United States.

Market Segmentation: Hydrocolloid dressing segment accounted for the highest share in global biomaterial wound dressing market.

Hydrocolloid dressings are bandages made of gel-forming agents such as gelatin and pectin that form a moist environment with the body that promotes healing. The hydrocolloid dressings absorb fluid from the wound and are generally recommended for minor burns, leg ulcers, pressure sores, and traumatic injuries. Such dressings can be kept for several days, as it slowly aids the healing process and maintains the wound environment. Hydrocolloid dressings are available in the market in various shapes and sizes. The widely used hydrocolloid dressing brands available in the market include Duoderm GCF, Comfeel, Actiderm, and Hydrosol.

The biomaterial wound dressing market is classified into wounds, burns, ulcers, and others by the application. The wound segment held a significant share in the market growth. Wounds dominated the biomaterial wound dressing market in the forecast period. Surgical wound contributes majorly to segmental growth across the globe. A surgical wound is a cut that is generally made by using a scalpel during the surgical procedure. There are primarily two types of surgical wounds following surgery, including incisional wounds and excisional wounds. Incisional wounds are made by cutting through fat, skin, and muscle, enabling body parts to be removed or repaired. The biomaterial wound dressings play an important role in controlling any postoperative bleeding, offering protection to newly developed tissue, and easing pain.

Geographical Penetration: North America is the dominating region during the forecast period.

The North American market dominated the largest market share in the global biomaterial wound dressing market in the forecast period. Factors augmenting the North American market's growth include the increasing incidence of pressure ulcers and a rising number of burning injury cases. Further, the rising number of surgical procedures and the presence of major players are also estimated to contribute to the market's growth.

Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally due to the growing aging population coupled with the increasing prevalence of ulcers, increasing number of burn cases, and the rising prevalence of diabetes across the Asia Pacific economies. By 2020, there were 255 million elders, representing at least 17.8% of the entire Chinese population. With the age dynamics, ulcer cases among the population of Asia-Pacific are expected to grow, which is expected to increase the chances of wounds.

Competitive Landscape:

The biomaterial wound dressing market is dominated by a few companies. Some of the key players in the market's growth include 3M Company, ConvaTec Group PLC, DermaRite Industries LLC, B. Braun Melsungen AG, Hollister Incorporated, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and Medtronic PLC, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global biomaterial wound dressing market. In August 2022, The 3M Health Care's medical solutions business announced upgrades to advance the delivery of certain wound care technologies. This new biomaterial wound unit, named 3M VAC Ulta therapy unit, was introduced at no increased cost to the customer. It is used for patients with open soft tissue wounds to help cleanse and stimulate the formation of granulation tissue. This kit helps to soften, solubilize, disrupt, and remove thick and non-viable tissue when immediate wound cleansing is needed. 3M company offers a wide range of wound care solutions. 3M developed the new dressing kit to simplify various dressing applications. In January 2022, ConvaTec Group entered into a definitive agreement to acquire Triad Life Sciences Inc, which develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns. This acquisition strengthens Convatec's Advanced Wound Care position in the United States and provides an innovative technology platform that enhances advanced wound management and patient outcomes.

COVID-19 Impact: Negative impact on the global biomaterial wound dressing market.

The outbreak of the COVID-19 pandemic is expected to derail the biomaterial wound dressing market's growth in 2020. The decline in accidents and the number of hospital visits is the major factor that has negatively impacted the biomaterial wound dressing market growth in 2020. However, the market is expected to have a negative impact due to the decrease in road accidents due to strict lockdown conditions and work-from-home facilities to avoid contamination of COVID-19.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising incidence of surgical procedures
      • 4.1.1.2. An increasing number of sports-related injuries
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness of advanced wound care products
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Hydrocolloids*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Alginate Dressing
    • 7.3.3. Skin Substitutes
    • 7.3.4. Others

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Wound*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Burns
    • 8.3.3. Ulcers
    • 8.3.4. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. The U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. The U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. The Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. 3M Company*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. ConvaTec Group PLC
  • 11.3. DermaRite Industries LLC
  • 11.4. B. Braun Melsungen AG
  • 11.5. Hollister Incorporated
  • 11.6. Integra LifeSciences Holdings Corporation
  • 11.7. Johnson & Johnson
  • 11.8. Medtronic PLC
  • 11.9. Molnlycke Health Care AB
  • 11.10. Smith & Nephew PLC
  • 11.11. Hunan Sanzhong Medical Dressing Co., Ltd.
  • 11.12. Changzhou Hualian Health Dressing Co., Ltd.
  • 11.13. Yangzhou Super Union Medical Material Co., Ltd.
  • 11.14. Other Companies (*LIST NOT EXHAUSTIVE)

12. DataM Intelligence

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us